カテゴリー： QYResearch, 世界

心的外傷後ストレス障害治療法の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Post-Traumatic Stress Disorder Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18850）・商品コード：DATA909X18850
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、心的外傷後ストレス障害治療法の世界市場について調査・分析し、心的外傷後ストレス障害治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の心的外傷後ストレス障害治療法市場動向
・主要企業別マーケットシェア
・心的外傷後ストレス障害治療法の種類別市場規模2014-2019
（抗うつ薬、抗不安薬、その他）
・心的外傷後ストレス障害治療法の用途別市場規模2014-2019
（病院、診療所、その他）
・心的外傷後ストレス障害治療法の北米市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法の中国市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法の日本国内市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法の東南アジア市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法のインド市場：主要企業・種類別/用途別市場規模
・心的外傷後ストレス障害治療法の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Pfizer, Inc.、GlaxoSmithKline plc、Otsuka Pharmaceutical Co., Ltd、Novartis AG、AstraZeneca Plc、Azevan Pharmaceuticals, Inc.、Bionomics Ltd.、Tonix Pharmaceuticals Holding Corp.、Apotex, Inc.）
・心的外傷後ストレス障害治療法の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Post-Traumatic Stress Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post-Traumatic Stress Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.

Market segment by Type, the product can be split into
Antidepressants
Anti-Anxiety Drugs
Others

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Post-Traumatic Stress Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Post-Traumatic Stress Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Post-Traumatic Stress Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antidepressants
1.4.3 Anti-Anxiety Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Post-Traumatic Stress Disorder Therapeutics Market Size
2.2 Post-Traumatic Stress Disorder Therapeutics Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (2019-2025)
2.2.2 Post-Traumatic Stress Disorder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Post-Traumatic Stress Disorder Therapeutics Market Size by by Players
3.1.1 Global Post-Traumatic Stress Disorder Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Area Served
3.3 Key Players Post-Traumatic Stress Disorder Therapeutics Product/Solution/Service
3.4 Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2014-2019)
4.2 Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
5.2 Post-Traumatic Stress Disorder Therapeutics Key Players in North America
5.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
5.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application

6 Europe
6.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
6.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Europe
6.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type
6.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application

7 China
7.1 China Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
7.2 Post-Traumatic Stress Disorder Therapeutics Key Players in China
7.3 China Post-Traumatic Stress Disorder Therapeutics Market Size by Type
7.4 China Post-Traumatic Stress Disorder Therapeutics Market Size by Application

8 Japan
8.1 Japan Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
8.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Japan
8.3 Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Type
8.4 Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
9.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type
9.4 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application

10 India
10.1 India Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
10.2 Post-Traumatic Stress Disorder Therapeutics Key Players in India
10.3 India Post-Traumatic Stress Disorder Therapeutics Market Size by Type
10.4 India Post-Traumatic Stress Disorder Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
11.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Central & South America
11.3 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
11.4 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer, Inc.
12.1.1 Pfizer, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019))
12.1.5 Pfizer, Inc. Recent Development
12.2 GlaxoSmithKline plc
12.2.1 GlaxoSmithKline plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline plc Recent Development
12.3 Otsuka Pharmaceutical Co., Ltd
12.3.1 Otsuka Pharmaceutical Co., Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 AstraZeneca Plc
12.5.1 AstraZeneca Plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Plc Recent Development
12.6 Azevan Pharmaceuticals, Inc.
12.6.1 Azevan Pharmaceuticals, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.6.5 Azevan Pharmaceuticals, Inc. Recent Development
12.7 Bionomics Ltd.
12.7.1 Bionomics Ltd. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.7.5 Bionomics Ltd. Recent Development
12.8 Tonix Pharmaceuticals Holding Corp.
12.8.1 Tonix Pharmaceuticals Holding Corp. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
12.9 Apotex, Inc.
12.9.1 Apotex, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.9.5 Apotex, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Post-Traumatic Stress Disorder Therapeutics Key Market Segments
Table Key Players Post-Traumatic Stress Disorder Therapeutics Covered
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antidepressants Figures
Table Key Players of Antidepressants
Figuer Anti-Anxiety Drugs Figures
Table Key Players of Anti-Anxiety Drugs
Figuer Others Figures
Table Key Players of Others
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Post-Traumatic Stress Disorder Therapeutics Report Years Considered
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Post-Traumatic Stress Disorder Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Share by by Players (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by by Players in 2018
Table Global Post-Traumatic Stress Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Post-Traumatic Stress Disorder Therapeutics Product/Solution/Service
Table Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Type (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Application (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application in 2018
Figure North America Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Europe Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure China Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table China Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table China Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Japan Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure India Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table India Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table India Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Otsuka Pharmaceutical Co., Ltd Company Details
Table Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Otsuka Pharmaceutical Co., Ltd Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table AstraZeneca Plc Recent Development
Table Azevan Pharmaceuticals, Inc. Company Details
Table Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Azevan Pharmaceuticals, Inc. Recent Development
Table Bionomics Ltd. Company Details
Table Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Bionomics Ltd. Recent Development
Table Tonix Pharmaceuticals Holding Corp. Company Details
Table Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Tonix Pharmaceuticals Holding Corp. Recent Development
Table Apotex, Inc. Company Details
Table Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Apotex, Inc. Recent Development
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Regions in 2025
Figure North America Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product in 2025
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer, Inc.、GlaxoSmithKline plc、Otsuka Pharmaceutical Co., Ltd、Novartis AG、AstraZeneca Plc、Azevan Pharmaceuticals, Inc.、Bionomics Ltd.、Tonix Pharmaceuticals Holding Corp.、Apotex, Inc.

★調査レポート[心的外傷後ストレス障害治療法の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18850)販売に関する免責事項を必ずご確認ください。
★調査レポート[心的外傷後ストレス障害治療法の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 外傷性脳損傷診断の世界市場：規模・現状・予測2019-2025
    DATA909X19050 / QYResearch / 2019年11月25日 / ※当調査レポートでは、外傷性脳損傷診断の世界市場について調査・分析し、外傷性脳損傷診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（）、用途別（）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の外傷性脳損傷診断市場動向 ・主要企業別マーケットシェア ・外傷性脳損傷診断の種類別市場規模2014-2019 （） ・外傷性脳損傷診断の用途別市場規模2014-2019 （） ・外傷性脳損傷診断の北米市場：主要企業・種類別/用途別市場規模 ・外傷性脳損傷診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...The global Traumatic Brain Injury Diagnostic Market Size will reach 161.86 million US$ in 2025, from 37.51 million US$ in 2018, with a CAGR of 23.10% during the forecast period. This report focuses on the global Traumatic Brain Injury Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Traumatic Brain Injury Diagnostic development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions The key players covered in this study Banyan Biomarkers ImPACT Application BrainScope InfraScan BrainBox Solution Quanterix BioDirection ABCDx Oculogica Market segment by...
  • タービン応力評価装置(TSE)の世界市場：規模・現状・予測2019-2025
    DATA909X19058 / QYResearch / 2019年11月25日 / ※当調査レポートでは、タービン応力評価装置(TSE)の世界市場について調査・分析し、タービン応力評価装置(TSE)の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ハードウェア、ソフトウェア）、用途別（自動車＆運輸、エネルギー＆電気、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のタービン応力評価装置(TSE)市場動向 ・主要企業別マーケットシェア ・タービン応力評価装置(TSE)の種類別市場規模2014-2019 （ハードウェア、ソフトウェア） ・タービン応力評価装置(TSE)の用途別市場規模2014-2019 （自動車＆運輸、エネルギー＆電気、その他） ・タービン応力評価装置(TSE)の北米市場：主要企業・種類別/用途別市場規模 ・タービン応力評価装置(TSE)のヨーロッパ市場：主要企業・種類別/用途別市場規模...Turbine stress evaluator is an online monitoring system based on the most advanced software algorithms to estimate the service life of steam turbines.The turbine stress evaluator adjusts the curve based on the calculation of the actual turbine operation to further improve turbine start-up.By reducing turbine startup and load times, turbine stress, and the time it takes to reach the required turbine speed or load.In 2018, the global Turbine Stress Evaluator (TSE) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report...
  • HPV関連障害の世界市場：規模・現状・予測2019-2025
    DATA909X18552 / QYResearch / 2019年11月25日 / ※当調査レポートでは、HPV関連障害の世界市場について調査・分析し、HPV関連障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（予防、治療）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のHPV関連障害市場動向 ・主要企業別マーケットシェア ・HPV関連障害の種類別市場規模2014-2019 （予防、治療） ・HPV関連障害の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・HPV関連障害の北米市場：主要企業・種類別/用途別市場規模 ・HPV関連障害のヨーロッパ市場：主要企業・種類別/用途別市場規模...HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global HPV Associated Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HPV Associated Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players...
  • 強迫性障害治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18761 / QYResearch / 2019年11月25日 / ※当調査レポートでは、強迫性障害治療薬の世界市場について調査・分析し、強迫性障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（SSRI、TCA、その他）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の強迫性障害治療薬市場動向 ・主要企業別マーケットシェア ・強迫性障害治療薬の種類別市場規模2014-2019 （SSRI、TCA、その他） ・強迫性障害治療薬の用途別市場規模2014-2019 （病院、クリニック、研究所、その他） ・強迫性障害治療薬の北米市場：主要企業・種類別/用途別市場規模 ・強迫性障害治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D...

    • ◆H&Iグローバルリサーチのお客様（例）◆